This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Pitt M, Garside R, Stein K.A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. British Journal of Dermatology 154: 1137-1146, No. 6, Jun 2006
Rights and permissions
About this article
Cite this article
Corticosteroids remain first choice in atopic dermatitis. Pharmacoecon. Outcomes News 509, 1 (2006). https://doi.org/10.2165/00151234-200605090-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605090-00001